Dr Martens reports revenue boost

The Dr Martens brand was founded in 1960.

British footwear producer Dr Martens has announced positive results in its trading figures for the third quarter of 2024, covering the 13 weeks ending on 29th December of last year. In the third quarter of the 2025 fiscal year, the company’s revenue increased by 3 per cent on an adjusted ‘constant currency’ (CC) basis when compared to the same period in the previous year, to total GBP 267 million. By region on a CC basis, ‘direct to consumer’ (DTC) revenue in Q3 grew in the Americas by 2 per cent and Asia-Pacific (APAC) saw a 14 per cent boost, although Europe, the Middle East and Africa (EMEA) DTC produced zero growth). Group wholesale CC revenue increased by 9 per cent.

“Our Q3 trading was as expected and our outlook for FY25 remains unchanged. We have made good progress against our objective of turning around our USA performance, with USA DTC in positive growth in Q3,” said chief executive Ije Nwokorie. “We continue to actively manage our costs and are on track to meet our inventory reduction target for FY25. The team and I are squarely focused on returning the business to sustainable and profitable growth.”

The iconic Dr Martens brand was founded in 1960 in Northamptonshire, England. Produced originally for workers looking for tough and durable boots, its footwear was quickly adopted by diverse youth subcultures and associated musical movements. Today, these ‘Docs’ – or ‘DMs’ – are worn around the world, and are said to be a ‘symbol of empowerment and the wearer’s own individual attitude’.

Publishing Data

This article was originally published on page 2 of the March 2025 issue of SATRA Bulletin.

Other articles from this issue »

---